Company record
Genome-Based Diagnostics provides diagnostic testing services tailored to healthcare applications. The company offers nucleic acid amplification, antibody and antigen testing platforms capable of detecting viral, bacterial and fungal infections. It also supplies screening kits and collection devices for urine and swab samples. Its test portfolio includes assays for chlamydia, gonorrhea, Mycoplasma genitalium, trichomoniasis and high‑risk human papillomavirus types 16, 18, 31, 33, 45, 52, 58 and 67. Antibody tests have received FDA approval, and all services are delivered in a HIPAA‑compliant environment.
This directory record does not yet have a linked material-flow brief.